Cytosorbents Corp — Director's Dealing 2014

Feb 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2014-01-22

Reporting Person: Capponi Vincent (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-22	Common stock; par value $0.001 per share	S	100000	$0.27	Disposed	8150586	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-22	Stock Options	$0.035	M	100000	Disposed	2018-06-25	Common Stock (100000)	Direct

Footnotes

F1: The shares of common stock sold by Mr. Capponi pursuant to a 10b5-1 trading plan, adopted by the reporting person on June 14, 2011.

F2: These stock options were granted to Mr. Capponi on June 25, 2008.

F3: As reported on prior Form 4s these shares consist of (a) 418,086 shares of common stock; (b) 50,000 stock options with an exercise price of $1.65 that expire on 12/31/2016; (c) 1,100,000 stock options with an exercise price of $0.25 that expire on 1/16/2018 (d) 2,100,000 stock options with an exercise price of $0.035 that expire on 6/25/2018; (e) 400,000 stock options with an exercise price of $0.168 that expire on 1/28/2019; (f) 500,000 stock options with an exercise price of $0.173 that expire on 1/4/2020; (g) 2,032,500 stock options with an exercise price of $0.138 that expire on 5/5/2020; and (h) 1,550,000 stock options with an exercise price of $0.115 that expire on 4/4/2023.